In partnership with Quotient Sciences, the healthy volunteers have been successfully dosed in the first ever phase 1 human trial of a nanoformed drug candidate.
In partnership with Quotient Sciences, the healthy volunteers have been successfully dosed in the first ever phase 1 human trial of a nanoformed drug candidate.